Vivanco-Suarez J, Dibas M, Lopes DK, et al.
Safety and Effectiveness Assessment of the Surpass Evolve (SEASE): A Post-Market International Multicenter Study
73%
Complete occlusion rate at 10.2 months
| Number of patients | 305 |
| Number of aneurysms | 322 |
| Major stroke | 2% (6/293) |
| Procedure-related mortality | 0.7% (2/293) |
| Severe parent vesselÌýstenosis (≥70%) | 1.4% (3/211) |
This Investigator Initiated Study was funded wholly or in part by ŠÊ˜·³Ç. The funding source was not involved in study design, monitoring, data collection, statistical analysis, interpretation of results, or manuscript writing.
Journal of NeuroInterventional Surgery | 2024
Vivanco-Suarez J, Dibas M, Lopes DK, et al. Safety and effectiveness assessment of the surpass evolve (SEASE): a post-market international multicenter study. J Neurointerv Surg. Published online April 25, 2024. doi:10.1136/jnis-2024-021503
ŠÊ˜·³Ç or its affiliated entities own, use, or have applied for the following trademarks or service marks: ŠÊ˜·³Ç, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004693 v1.0